Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 3
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 1, 2005
Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese
Xiao Hui Liang, Wai Cheung, Chew Kiat Heng, De-Yun Wang
Therapeutics and Clinical Risk Management 2005, 1:243-246
Published Date: 15 October 2005
Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3
Shenxian Qian, George Somlo, Bingsen Zhou, Yun Yen
Therapeutics and Clinical Risk Management 2005, 1:231-241
Published Date: 15 October 2005
Gastrointestinal bleeding and massive liver damage in neuroleptic malignant syndrome
Guido Mannaioni, Roberto Baronti, Flavio Moroni
Therapeutics and Clinical Risk Management 2005, 1:225-229
Published Date: 15 October 2005
Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia
Madeleine Nowak, Petra Büttner, Beverly Raasch, Kym Daniell, Cindy McCutchan, Simone Harrison
Therapeutics and Clinical Risk Management 2005, 1:219-224
Published Date: 15 October 2005
Influence of anatomical site and topical formulation on skin penetration of sunscreens
Heather AE Benson, Vikram Sarveiya, Stacey Risk, Michael S Roberts
Therapeutics and Clinical Risk Management 2005, 1:209-218
Published Date: 15 October 2005
Inhibitors of selectin functions in the treatment of inflammatory skin disorders
Michael P Schön
Therapeutics and Clinical Risk Management 2005, 1:201-208
Published Date: 15 October 2005
The challenge of patient adherence
Leslie R Martin, Summer L Williams, Kelly B Haskard, M Robin DiMatteo
Therapeutics and Clinical Risk Management 2005, 1:189-199
Published Date: 15 October 2005
Adverse drug reaction reporting in New Zealand: implications for pharmacists
Monica Zolezzi, Nirasha Parsotam
Therapeutics and Clinical Risk Management 2005, 1:181-188
Published Date: 15 October 2005
Sputum analysis in diagnosis and management of obstructive airway diseases
Paige Lacy, Jennifer L Lee, Dilini Vethanayagam
Therapeutics and Clinical Risk Management 2005, 1:169-179
Published Date: 15 October 2005
Editorial || FREE PAPER ||
Garry Walsh
Therapeutics and Clinical Risk Management 2005, 1:167-167
Published Date: 15 October 2005